| ID | 209 |
|---|
| No | 209 |
|---|
| Brand Name | LANZAAR 50 |
|---|
| Ingredients | LOSARTAN POTASSIUM 50 MG |
|---|
| Dosage Form | FILM-COATED TABLETS |
|---|
| Primary Packaging | ALU-PVDC BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS AFTER MANUFACTURE |
|---|
| Pack Size | 3 X 10'S /BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION. STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE OVAL BICONVEX FILM COATED TABLETS WITH ''BERLIN'' ON ONE SIDE AND SCORED BETWEEN "L" AND "50" ON THE OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | BERLIN PHARMA LAO CO.,LTD |
|---|
| Manufacturer | BERLIN PHARMACEUTICAL INDUSTRY CO., LTD. |
|---|
| Country | THAILAND |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | STEP 1: RECEIVE (RENEW) |
|---|
| Applied Date | 27-JUN-2025 |
|---|
| FDD Registration No | 03 I 3710/12 |
|---|
| FDD Registration Date | 14-SEP-2022 |
|---|
| Expiry Date | 13-SEP-2025 |
|---|
